Daniel is a non executive director of Genome Research Ltd (Wellcome Sanger Institute) where he is also the Audit Committee Chair, and of BioCity Group ltd, a national biotech and medtech incubator, where he is also Audit committee Chair. Daniel has previously held executive director positions including as Chief Financial Officer at Volex plc, Fiberweb plc, CDT inc and Xenova plc and senior executive roles at PepsiCo Inc and Diageo plc.
He is also a former non executive director of the Biotech Industry Association and Panel member of the FRRP in the FRC.
Daniel has an MA (Hons) Law from Cambridge University and is a qualified chartered accountant, FCA, and barrister-at -law.